Stockscreener 앱 받기
2.045
1.68%
-0.035
전일 마감가:
$2.08
열려 있는:
$2.07
하루 거래량:
159.19K
Relative Volume:
0.13
시가총액:
$129.05M
수익:
$139.77M
순이익/손실:
$-97.62M
주가수익비율:
-1.2943
EPS:
-1.58
순현금흐름:
$-61.71M
1주 성능:
+3.28%
1개월 성능:
+20.29%
6개월 성능:
+2.25%
1년 성능:
-14.08%
1일 변동 폭
$2.01
$2.0886
1주일 범위
$1.81
$2.0886
52주 변동 폭
$0.9897
$2.485
Macrogenics Inc Stock (MGNX) Company Profile
명칭
Macrogenics Inc
전화
301-251-5172
주소
9704 MEDICAL CENTER DRIVE, Rockville, MD
Compare MGNX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
2.04 | 131.58M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.45 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
769.77 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.33 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
294.56 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 재개 | Barclays | Overweight |
| 2024-11-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-05-10 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-04-26 | 개시 | B. Riley Securities | Buy |
| 2024-04-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-03-04 | 재확인 | BTIG Research | Buy |
| 2024-02-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-03-17 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-11-22 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-14 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | 다운그레이드 | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-02-28 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-02-04 | 개시 | SMBC Nikko | Outperform |
| 2021-11-17 | 재개 | Guggenheim | Buy |
| 2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 업그레이드 | Barclays | Underweight → Overweight |
| 2020-12-22 | 재개 | H.C. Wainwright | Buy |
| 2020-08-03 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-06-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-05-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2019-12-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-11-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-05-03 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2019-04-12 | 개시 | Guggenheim | Neutral |
| 2019-02-07 | 업그레이드 | Citigroup | Sell → Buy |
| 2019-02-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2019-02-06 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2018-12-10 | 다운그레이드 | Raymond James | Outperform → Underperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-03-05 | 개시 | H.C. Wainwright | Buy |
| 2017-03-31 | 개시 | Raymond James | Outperform |
모두보기
Macrogenics Inc 주식(MGNX)의 최신 뉴스
MGNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
MacroGenics (MGNX) director Jay Siegel to step down after 2026 meeting - Stock Titan
Whats the profit margin of MacroGenics IncEarnings Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus
MacroGenics to Participate in Upcoming Investor Conferences - The Manila Times
Cancer drug developer MacroGenics lines up March investor talks - Stock Titan
Why is MacroGenics stock sinking Tuesday? - MSN
MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates - MSN
MacroGenics stock falls after FDA places partial clinical hold By Investing.com - Investing.com South Africa
MacroGenics stock falls after FDA places partial clinical hold - Investing.com Nigeria
MacroGenics (MGNX) Faces FDA Setback with Partial Hold on Lorige - GuruFocus
MacroGenics stock drops after FDA partial hold (MGNX:NASDAQ) - Seeking Alpha
FDA Places Partial Clinical Hold on MacroGenics Trial - TipRanks
FDA Imposes Partial Clinical Hold on MacroGenics' (MGNX) Study - GuruFocus
Why Is MacroGenics Stock Sinking Tuesday? - Bitget
MacroGenics Pauses Enrollment Of Participants In LINNET Trial On FDA's Partial Clinical Hold - RTTNews
MacroGenics says FDA places partial clinical hold on Phase 2 LINNET study - TipRanks
FDA halts new enrollment in MacroGenics (NASDAQ: MGNX) LINNET study - Stock Titan
Macrogenics announces pausing of enrollment of new study participants in Linnet trial - marketscreener.com
MacroGenics Faces Partial Clinical Hold from FDA on LINNET Study of Lorigerlimab in Gynecologic Cancers - Quiver Quantitative
FDA halts new enrollment in cancer trial after severe side effects - Stock Titan
Panic Selling: Will MacroGenics Inc outperform the market in YEAR2025 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn
Armistice Capital (MGNX) discloses 6.32M shares, 9.99% stake via Master Fund - Stock Titan
MacroGenics (NASDAQ: MGNX) SVP awarded RSUs, options and exercises units - Stock Titan
MacroGenics (NASDAQ: MGNX) CFO awarded stock options and RSUs - Stock Titan
Why MacroGenics Inc. stock is favored by pension fundsEarnings Beat & Accurate Entry/Exit Alerts - mfd.ru
Income Plays: Will MacroGenics Inc outperform the market in YEARPortfolio Return Report & Capital Protection Trade Alerts - baoquankhu1.vn
MGNX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why MacroGenics Inc. stock remains a top recommendationJuly 2025 Opening Moves & Free Daily Entry Point Trade Alerts - mfd.ru
Scott Koenig increases MacroGenics (MGNX) stake via 15,831 RSU conversion - Stock Titan
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Big Picture: Is Badger Meter Inc stock suitable for long term investing2025 Bull vs Bear & Weekly Market Pulse Alerts - baoquankhu1.vn
Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication - Seeking Alpha
Aug Swings: Whats the fair value of Humacyte Inc Equity Warrant stockJuly 2025 Volume & Daily Chart Pattern Signals - baoquankhu1.vn
Retail Trends: What is the next catalyst for MacroGenics IncQuarterly Profit Report & Advanced Swing Trade Entry Plans - baoquankhu1.vn
MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
MacroGenics (NASDAQ:MGNX) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat
Weekly Trades: Is MacroGenics Inc attractive for institutional investorsWeekly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Will MacroGenics Inc outperform the market in YEAR2025 Biggest Moves & High Conviction Trade Alerts - baoquankhu1.vn
MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Hold" by Analysts - MarketBeat
[Latest] Global T-Cell Engagers Market Size/Share Worth USD 18.8 Billion by 2034 at a 21.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Is Via Renewables Inc impacted by rising ratesWeekly Trend Recap & Long-Term Growth Stock Strategies - baoquankhu1.vn
MacroGenics (NASDAQ:MGNX) Stock Price Crosses Above 50 Day Moving Average – What’s Next? - Defense World
Meme Stocks: Is MacroGenics Inc attractive for institutional investorsLayoff News & Smart Money Movement Alerts - baoquankhu1.vn
Will MacroGenics Inc. stock benefit from green energy trendsJuly 2025 Sentiment & Consistent Income Trade Ideas - Улправда
How supply chain issues affect MacroGenics Inc. stockQuarterly Performance Summary & Weekly High Return Opportunities - Улправда
Market Leaders: How supply chain issues affect MacroGenics Inc. stockWeekly Investment Report & Step-by-Step Trade Execution Guides - ulpravda.ru
Will MacroGenics Inc. stock gain from government policiesEarnings Overview Summary & Risk Controlled Swing Alerts - Улправда
Exploring Sarah Faizy's Journey in Life Sciences Leadership - BioBuzz
How MacroGenics Inc. stock performs in rising dollar environment2026 world cup usa national team quarterfinals young talents pressing system odds analysis breakdown - ulpravda.ru
There's No Escaping MacroGenics, Inc.'s (NASDAQ:MGNX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
Macrogenics Inc (MGNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.50%
자본화:
|
볼륨(24시간):